Semler Scientific, INC 8-K filings

Semler Scientific, Inc. has been acquired by Strive, Inc., becoming a wholly-owned subsidiary, with Strive guaranteeing Semler's 4.25% Convertible Senior Notes due 2030.

Semler Scientific, Inc. stockholders approved the merger agreement with Strive, Inc. and related executive compensation at a special meeting on January 13, 2026.

Semler Scientific announces a 37% headcount reduction and cost-saving measures while providing supplemental disclosures for its pending all-stock merger with Strive, Inc.

Semler Scientific files supplemental unaudited pro forma financials for its all-stock acquisition by Strive, Inc., detailing combined financial outlook.

Semler Scientific announced a new Bitcoin dashboard for public disclosure and reported Q3 2025 BTC Yield, while also referencing a proposed merger with Strive Inc.

Strive, Inc. announced the closing of its initial public offering, raising $149.3 million, and significantly increased its Bitcoin holdings to approximately 7,525 BTC, ahead of its planned acquisition of Semler Scientific.

Semler Scientific provides supplemental disclosures on Strive's financial position and its upsized $160 million perpetual preferred stock offering, ahead of their all-stock merger.

Semler Scientific announced the resignation of its Chief Financial Officer, Renae Cormier, with CEO Dr. Douglas Murphy-Chutorian assuming the interim CFO position.

Semler Scientific announced preliminary third-quarter 2025 financial results, including significant unrealized gains from Bitcoin holdings, alongside a substantial reduction in Q4 revenue guidance due to declining QuantaFlo device usage.

Semler Scientific Inc. borrowed $20 million from Coinbase Credit, collateralized by its Bitcoin holdings, to fund a U.S. Department of Justice settlement.

Strive, Inc. is acquiring Semler Scientific, Inc. in an all-stock transaction, further solidifying its strategic shift to a Bitcoin treasury company.

Semler Scientific, Inc. has entered into a definitive merger agreement to become a wholly owned subsidiary of Strive, Inc., with Semler Sci shareholders receiving 21.05 shares of Strive Class A Common Stock for each Semler Sci share.

Strive, Inc. will acquire Semler Scientific, Inc. in an all-stock transaction, creating a combined entity with over 10,900 Bitcoin holdings and a focus on preventative diagnostics.

Semler Scientific agrees to a $29.75 million settlement with the DOJ over False Claims Act allegations and anticipates a significant revenue decline due to customer reductions and delayed FDA clearance.

Semler Scientific's stockholders approved the election of a director, executive compensation, and an increase in authorized common stock, while rejecting blank-check preferred stock.

Semler Scientific reported a significant increase in Bitcoin holdings and unrealized gains in Q2 2025, despite a 43% year-over-year decrease in healthcare revenues.

Semler Scientific announced significant progress in its At-The-Market (ATM) stock offering, raising $194.3 million, and further increased its Bitcoin holdings to 5,021 BTC with a 31.3% year-to-date yield.

Semler Scientific files a corrected 8-K, revising its unrealized gain from Bitcoin holdings and providing updates on its ATM offering program and Bitcoin acquisitions.

Semler Scientific reported preliminary unaudited Q2 2025 financial results, including an anticipated $90.5 million unrealized gain from Bitcoin holdings and progress on its $500 million at-the-market offering.

Semler Scientific, Inc. announced the formation of CardioVanta, Inc., a new wholly-owned subsidiary dedicated to early detection of heart failure and cardiac arrhythmia monitoring, which will seek outside investment.

Semler Scientific, Inc. has adopted its Fifth Amended and Restated Bylaws, primarily to clarify provisions related to stockholder actions and align indemnification clauses, while also establishing exclusive forum provisions for certain legal disputes.

Semler Scientific, Inc. announced a significant strategic shift by appointing a Director of Bitcoin Strategy and outlining an ambitious plan to acquire 105,000 Bitcoins by year-end 2027, funded through equity, debt, and operational cash flows.

Semler Scientific, Inc. has adopted Fourth Amended and Restated Bylaws, effective June 4, 2025, to update corporate governance procedures and align with current Delaware General Corporation Law.

Semler Scientific, a medical device company, announced further Bitcoin acquisitions funded by its $500 million At-The-Market (ATM) offering, bringing total holdings to 4,449 BTC, and launched a dedicated Bitcoin dashboard for investor transparency.

Semler Scientific updates investors on its Bitcoin holdings, ATM offering program, and introduces BTC Yield as a Key Performance Indicator.

Semler Scientific appoints Natalie Brunell to its Board of Directors and Bitcoin Strategy Committee, granting her stock options as part of her compensation.

Semler Scientific reported a net loss of $64.7 million for Q1 2025, driven by unrealized losses on its bitcoin holdings and increased operating expenses, despite a 22.2% year-to-date BTC yield.

Semler Scientific updates investors on its ATM offering, recent Bitcoin acquisitions, and the use of BTC Yield as a key performance indicator.

Semler Scientific announces the purchase of an additional 165 bitcoins, bringing its total holdings to 3,467, and reports a year-to-date BTC yield of 23.8%.

Semler Scientific announces the purchase of an additional 111 bitcoins, bringing its total holdings to 3,303, and highlights a year-to-date BTC yield of 23.5%.